Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 26.01
-0.57 (-2.14%)
At close: Aug 22, 2025, 2:57 PM CST
SHA:601089 Revenue
Beijing Foyou Pharma CO.,LTD had revenue of 803.50M CNY in the quarter ending June 30, 2025, a decrease of -5.78%. This brings the company's revenue in the last twelve months to 3.42B, up 1.75% year-over-year. In the year 2024, Beijing Foyou Pharma CO.,LTD had annual revenue of 3.45B with 3.17% growth.
Revenue (ttm)
3.42B
Revenue Growth
+1.75%
P/S Ratio
3.62
Revenue / Employee
939.66K
Employees
3,644
Market Cap
12.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.45B | 106.01M | 3.17% |
| Dec 31, 2023 | 3.34B | 99.48M | 3.07% |
| Dec 31, 2022 | 3.24B | 402.44M | 14.18% |
| Dec 31, 2021 | 2.84B | 302.37M | 11.93% |
| Dec 31, 2020 | 2.54B | 110.67M | 4.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.90B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |